U.S. lab says AIDS vaccine is nearing success in three or four years

U.Sresearchers say a new AIDS vaccine is nearing success and will be available within three or four yearsIf the vaccine is successful, it could save tens of millions of lives around the worldThe research has been quietly under way for 15 years and is now in its final sprintThe lab, which was built by GeoVax withat Emory University, the Centers for Diseasecontrol in
and the NationalHealth, is likely to be the first to make a breakthrough, albeit on a smaller scale than many of its peers"The results of the returned experiments show a very strong immune response in individuals using this vaccine," said Hildebrand, chief executive of GeoVaxDr Harriet Robinson, of Emory University's Miao Research Center, said the vaccine uses a virus that has a gene similar to HIV, but it does not infect peoplediseaseThe body's immune system remembers the virus and starts to start when it is invaded by the actual virusThe experiment has so far been so successful that researchers even predict it will be completed in a yearDr Robinson said: "The vaccine increases the number of antibodies and white blood cells at the same time, and it is a two-pronged approach to hiv suppression "
the vaccine has been effective in previous trials of HIV in apes, not only to prevent infection, but even to cure individuals who have been infected with disease soured The researchers believe the effect could also be found in humans (rereproduced from "China News Network")